GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q1 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,297,000 | +15.1% | 52,490 | +14.6% | 0.30% | +29.6% |
Q1 2022 | $1,995,000 | -0.1% | 45,808 | +1.1% | 0.23% | -0.4% |
Q4 2021 | $1,997,000 | +15.4% | 45,290 | +0.0% | 0.23% | +1.8% |
Q3 2021 | $1,730,000 | -8.0% | 45,276 | -4.1% | 0.23% | -13.0% |
Q2 2021 | $1,880,000 | +17.1% | 47,205 | +4.9% | 0.26% | +7.0% |
Q1 2021 | $1,606,000 | -5.3% | 44,996 | -2.3% | 0.24% | -15.0% |
Q4 2020 | $1,695,000 | +2.2% | 46,064 | +4.6% | 0.29% | -11.1% |
Q3 2020 | $1,658,000 | -1.8% | 44,057 | +6.4% | 0.32% | -11.3% |
Q2 2020 | $1,689,000 | +24.5% | 41,401 | +15.6% | 0.36% | +2.2% |
Q1 2020 | $1,357,000 | -19.4% | 35,818 | +0.0% | 0.36% | +0.8% |
Q4 2019 | $1,683,000 | +12.0% | 35,813 | +1.7% | 0.35% | +0.6% |
Q3 2019 | $1,503,000 | +12.0% | 35,219 | +5.0% | 0.35% | +7.7% |
Q2 2019 | $1,342,000 | -4.1% | 33,544 | +0.1% | 0.33% | -8.9% |
Q1 2019 | $1,400,000 | +11.5% | 33,494 | +5.0% | 0.36% | +0.3% |
Q4 2018 | $1,256,000 | -41.2% | 31,901 | -39.9% | 0.36% | +22.3% |
Q3 2018 | $2,136,000 | +109.2% | 53,108 | +109.6% | 0.29% | +1.4% |
Q2 2018 | $1,021,000 | +12.8% | 25,339 | +9.4% | 0.29% | +7.5% |
Q1 2018 | $905,000 | +19.1% | 23,164 | +8.2% | 0.27% | +19.6% |
Q4 2017 | $760,000 | -32.8% | 21,414 | -23.1% | 0.22% | -40.7% |
Q3 2017 | $1,131,000 | -4.0% | 27,849 | +1.9% | 0.38% | -9.6% |
Q2 2017 | $1,178,000 | +4.7% | 27,324 | +2.4% | 0.42% | +3.5% |
Q1 2017 | $1,125,000 | +10.5% | 26,694 | +0.9% | 0.40% | +2.0% |
Q4 2016 | $1,018,000 | -11.2% | 26,444 | -0.4% | 0.40% | -11.6% |
Q3 2016 | $1,146,000 | +2.4% | 26,559 | +2.9% | 0.45% | -2.2% |
Q2 2016 | $1,119,000 | +9.3% | 25,809 | +2.2% | 0.46% | +6.8% |
Q1 2016 | $1,024,000 | -1.8% | 25,244 | -2.3% | 0.43% | -15.0% |
Q4 2015 | $1,043,000 | +7.3% | 25,844 | +2.2% | 0.50% | +1.2% |
Q3 2015 | $972,000 | -5.2% | 25,279 | +2.7% | 0.50% | +1.4% |
Q2 2015 | $1,025,000 | -4.7% | 24,604 | +5.6% | 0.49% | -3.7% |
Q1 2015 | $1,075,000 | +10.6% | 23,289 | +2.4% | 0.51% | -0.6% |
Q4 2014 | $972,000 | +7.2% | 22,739 | +15.3% | 0.51% | -3.9% |
Q3 2014 | $907,000 | +19.2% | 19,719 | +38.5% | 0.54% | +18.6% |
Q2 2014 | $761,000 | +11.4% | 14,234 | +11.4% | 0.45% | +7.9% |
Q1 2014 | $683,000 | +5.6% | 12,783 | +5.4% | 0.42% | -3.0% |
Q4 2013 | $647,000 | – | 12,123 | – | 0.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |